| Expression pattern: |
UP |
| Associated gene: |
MAPK1, FNDC3B, Ki67, BCL2, BAX |
| Associated microRNA: |
miR-136-5p |
| Biological function: |
Promotes ESCC cell proliferation, migration, invasion, EMT, metastasis and tumor growth, while inhibiting apoptosis. |
| Molecular mechanism: |
circ_FNDC3B functions as a miR-136-5p sponge to relieve miR-136-5p-mediated repression of MAPK1, thereby promoting ESCC progression. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); apoptosis (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
Actinomycin D / DRB Stability Assay; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Western Blot; Annexin V/PI Flow Cytometry; Luciferase Reporter Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Bioinformatics Analysis |
| Clinical significance: |
circ_FNDC3B upregulation was related to T-stage III, lymph node metastasis, and poor prognosis. |
| Description: |
circ_FNDC3B is up-regulated in ESCC tissues and cells and acts as an oncogenic circRNA. Its knockdown suppresses proliferation, migration, invasion, EMT and xenograft tumor growth while promoting apoptosis. Mechanistically, circ_FNDC3B sponges miR-136-5p to increase MAPK1 expression, forming a circ_FNDC3B/miR-136-5p/MAPK1 axis associated with malignant ESCC progression. |
| Confidence score: |
0.7859 |